Acta Scientific Neurology

Review Article Volume 3 Issue 1

MIND Diet in Delaying Parkinsonian Signs in Elderly Population

Rajib Dutta1* and Swatilekha Roy Sarkar2#

1MD, Neurology, India

2MDS, Consultant Orthodontist, India

*Corresponding Author: Rajib Dutta, MD, Neurology, India. E-mail:

Received: December 17, 2019; Published: December 23, 2019



   Parkinsonian signs like unsteadiness of gait, rigidity, bradykinesia and tremor are very common in elderly population and can affect activities of daily living. It can predict incidence of dementia in future and is the real reason behind mortality and disability because of its progressing nature. In fact there is no known definite treatment in clinical practice at this moment. Few preventive strategies can be used to control this loss of motor functions in this age group like special diet patterns, physical activity like aerobic exercise, biofeedback balance training, avoidance of antipsychotic drugs (APD) etc. Here in this article we will review about the dietary patterns specially MIND(Mediterranean DASH intervention of neurological delay) which can delay parkinsonism and parkinsonian signs in old age population.

Keywords: MIND; Healthy Diet; Parkinsonism; Parkinsonian; Elderly; Motor Decline



  1. Buchman AS., et al. “Parkinsonism in Older Adults and Its Association with Adverse Health Outcomes and Neuropathology”. The Journals of Gerontology. Series A, Biological Sciences 4 (2016): 549-556.
  2. Louis ED and Bennett DA. “Mild Parkinsonian signs: an overview of an emerging concept”. Movement Disorders 22 (2007): 1681-1688.
  3. Louis ED., et al. “Functional correlates and prevalence of mild parkinsonian signs in a community population of older people”. Arch Neurology 62 (2005): 297-302.
  4. Louis ED., et al. “Mild parkinsonian signs are associated with increased risk of dementia in a prospective, population-based study of elders”. Movement Disorders 25 (2010): 172-178.
  5. Zhou G., et al. “Association between mild parkinsonian signs and mortality in an elderly male cohort in China”. Journal of Clinical Neuroscience 17 (2010): 173-176.
  6. Bennett DA., et al. “Prevalence of parkinsoniansigns and associated mortality in a community population of older people”. The New England Journal of Medicine 334 (1996): 71-76.
  7. Buchman AS., et al. “Cerebrovascular disease pathology and parkinsonian signs in old age”. Stroke11 (2011): 3183-3189.
  8. Iwasaki Y., et al. “An autopsied case of argyrophilic grain dementia with parkinsonism due to multiple lacunar infarctions”. Brain and Nerve5 (2013): 583-587.
  9. Boyle PA., et al. “Parkinsonian signs in subjects with mild cognitive impairment”. Neurology 12 (2005): 1901-1906.
  10. Caligiore D., et al. “Parkinson’s disease as a system-level disorder”. Npj Parkinson’s Disease 2 (2016): 16025.
  11. Joutsa J., et al. “Localizing parkinsonism based on focal brain lesions”. Brain 8 (2018): 2445e2456.
  12. Willett WC. “Overview and perspective in human nutrition”. Asia Pacific Journal of Clinical Nutrition 1 (2008): 1-4.
  13. Kalaria RN. “Vascular basis for brain degeneration: faltering controls and risk factors for dementia”. Nutrition Reviews 68 (2010): S74-S87.
  14. O Akinyemi., et al. “Vascular Risk Factors and Neurodegeneration in Ageing Related Dementias: Alzheimer’s Disease and Vascular Dementia”. Current Alzheimer Research6 (2013): 642-653.
  15. Ball N., et al. “Parkinson’s Disease and the Environment”. Frontiers in Neurology (2019).
  16. Chen H and Ritz B. “The Search for Environmental Causes of Parkinson’s Disease: Moving Forward”. Journal of Parkinson’s Disease1 (2018): S9-S17.
  17. Włodarek D. “Role of Ketogenic Diets in Neurodegenerative Diseases (Alzheimer’s Disease and Parkinson’s Disease)”. Nutrients 1 (2019): 169.
  18. Sääksjärvi K., et al. “A cohort study on diet and the risk of Parkinson’s disease: the role of food groups and diet quality”. British Journal of Nutrition12 (2012): 329-337.
  19. Park M., et al. “Consumption of milk and calcium in midlife and the future risk of Parkinson disease”. Neurology 6 (2005): 1047-1051.
  20. Chen H., et al. “Consumption of dairy products and risk of Parkinson’s disease”. American Journal of Epidemiology 165 (2007): 998-1006.
  21. Bianchi VE., et al. “Effect of nutrition on neurodegenerative diseases. A systematic review”. Nutritional Neuroscience (2019): 1-25.
  22. Karstens AJ., et al. “Associations of the Mediterranean diet with cognitive and neuroimaging phenotypes of dementia in healthy older adults”. The American Journal of Clinical Nutrition (2019).
  23. Román GC., et al. “Extra-virgin olive oil for potential prevention of Alzheimer disease”. Revue Neurologique (2019).
  24. EH Martinez-Lapiscina., et al. “Mediterranean diet improves cognition: the PREDIMED NAVARRA randomised trial”. Journal of Neurology, Neurosurgery, and Psychiatry 84 (2013): 1318-1325.
  25. Féart C., et al. “Potential benefits of adherence to the Mediterranean diet on cognitive health”. Proceedings of the Nutrition Society01 (2012): 140-152.
  26. Lin PH., et al. “Blood pressure-lowering mechanisms of the DASH dietary pattern”. Journal of Nutrition and Metabolism (2012): 2012472396.
  27. Maris SA., et al. “Interactions of the DASH diet with the renin-angiotensin-aldosterone system”. Current Developments in Nutrition (2019).
  28. Agarwal P., et al. “Mind Diet Associated with Reduced Incidence and Delayed Progression of Parkinsonism in Old Age”. The Journal of Nutrition, Health and Aging (2018).
  29. Fleischman DA., et al. “Parkinsonian Signs and Functional Disability in Old Age”. Experimental Aging Research1 (2007): 59-76.
  30. Rajput AH., et al. “Alzheimer’s Disease and Idiopathic Parkinson’s Disease Coexistence”. Journal of Geriatric Psychiatry and Neurology3 (1993): 170-176.
  31. MacCarthy B and Brown R. “Psychosocial factors in Parkinson’s disease”. British Journal of Clinical Psychology1 (1989): 41-52.
  32. Wilson RS., et al. “Progression of gait disorder and rigidity and risk of death in olderpersons”. Neurology 58 (2002) 1815-1819.
  33. Wilson RS., et al. “Parkinsonianlike signs and risk of incident Alzheimer disease in older persons”. Archives of Neurology 60 (2003): 539-544.
  34. Bennett DA., et al. “Prevalence of parkinsonian signs and associated mortality in a community population of older people”. New EnglandJournal of Medicine 334 (1996): 71-76.
  35. Ma SY., et al. “Unbiased morphometricalmeasurements show loss of pigmented nigral neurons with ageing”. Neuropathology and Applied Neuropathology 25 (1999): 394-399.
  36. Ross GW., et al. “Parkinsonian signs and substantia nigra neuron density in decendants elders without PD”. Annals of Neurology 56 (2004): 532-539.
  37. Schneider J.A., et al. “Detection of nigral pathology in AD”. Journal of Histochemistry and Improved Cytochemistry 50 (2002): 99.
  38. Liu Y., et al. “Pathological correlates of extrapyramidal signs in Alzheimer disease”. Annals of Neurology 41 (1997): 368-374.
  39. Zijlmans JCM., et al. “Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis”. Movement Disorders 19 (2004): 630-640.
  40. World Health Organ. “Diet, nutrition and the prevention of chronic diseases”. World Health Organization Technical Report Series (2003): 916.
  41. Di Giovanni G. “The Basal Ganglia Pathophysiology: Recent Advances”. Transworld Research Network, Kerala, India (2007).
  42. Jenner P and Olanow CW. “The pathogenesis of cell death in Parkinson’s disease”. Neurology 66 (2006): S24-S36.
  43. Hornykiewics O. “Neurochemical pathology and aetiology of Parkinson’s disease: basic facts and hypothetical possibilities”. Mount Sinai Journal of Medicine 55 (1988): 11-20.
  44. Yurek DM and Sladek JR Jr. “Dopamine cell replacement: Parkinson’s disease”. Annual Review of Neuroscience 13 (1990): 415-440.
  45. Alexi T., et al. “Neuroprotective strategies for basal ganglia degeneration: Parkinson’s and Huntington’s diseases”. Progress in Neurobiology 60 (2000): 409-470.
  46. Di Giovanni G. “Will it ever become possible to prevent dopaminergic neuronal degeneration?” CNS Neurol Disord Drug Targets1 (2008): 28-44.
  47. Simon KC., et al. “Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease”. Neurology 69 (2007): 1688-1695.
  48. G Di Giovanni., et al. “Birth, Life and Death of Dopaminergic Neurons in the Substantia Nigra”. Journal of Neural Transmission Supplementa 73 (2009).
  49. Munoz-Garcia MI., et al. “A priori” Dietary Patterns and Cognitive Function in the SUN Project”. Neuroepidemiology (2019): 1-13.
  50. Buchman AS., et al. “Nigral pathology and parkinsonian signs in elders without Parkinson disease”. Annals of Neurology 71 (2012): 258-266.
  51. Gao X., et al. “Prospective study of dietary pattern and risk of Parkinson disease”. The American Journal of Clinical Nutrition5 (2007): 1486-1494.
  52. Alcalay RN., et al. “The association between Mediterranean diet adherence and Parkinson’s disease”. Movement Disorders 6 (2012): 771-774.
  53. Okubo H., et al. “Dietary patterns and risk of Parkinson’s disease: a case-control study in Japan”. European Journal of Neurology 5 (2012): 681-688.
  54. Saaksjarvi K., et al. “A cohort study on diet and the risk of Parkinson’s disease: the role of food groups and diet quality”. British Journal of Nutrition 2 (2013): 329-337.
  55. Leon-Munoz LM., et al. “Mediterranean diet and risk of frailty in community-dwelling older adults”. Journal of the American Medical Directors Association 12 (2014): 899-903.
  56. Milaneschi Y., et al. “Mediterranean diet and mobility decline in older persons”. Experimental Gerontology 4 (2011): 303-308.
  57. Shahar DR., et al. “Adherence to mediterranean diet and decline in walking speed over 8 years in community-dwelling older adults”. Journal of the American Geriatrics Society 10 (2012): 1881-1888.
  58. Morris MC., et al. “MIND diet associated with reduced incidence of Alzheimer’s disease”. Alzheimers Dement9 (2015): 1007-1014.
  59. Morris MC., et al. “MIND diet slows cognitive decline with aging”. Alzheimers Dement9 (2015): 1015-1022.
  60. Cherian L., et al. “Mediterranean-Dash Intervention for Neurodegenerative Delay (MIND) Diet Slows Cognitive Decline After Stroke”. The Journal of Prevention of Alzheimer's Disease (2019): 1-7.
  61. Shukitt-Hale B., et al. “Thebeneficial effects of berries on cognition, motor behaviour and neuronal function in ageing”. British Journal of Nutrition 10 (2015): 1542-1549.
  62. Joseph JA., et al. “Grape Juice, Berries, and Walnuts Affect Brain Aging and Behavior”. The Journal of Nutrition9 (2009): 1813S-1817S.
  63. Schrager MA., et al. “Effects of blueberry supplementation on measures of functional mobility in older adults”. Applied Physiology, Nutrition, and Metabolism 6 (2015): 543-549.
  64. Belvisi D., et al. “Modifiable risk and protective factors in disease development, progression and clinical subtypes of Parkinson’s disease: What do prospective studies suggest?” Neurobiology of Disease (2019): 104671.
  65. Cesari M., et al. “Antioxidants and physical performance in elderly persons: the Invecchiare in Chianti (InCHIANTI) study”. The American Journal of Clinical Nutrition2 (2004): 289-294.
  66. Bartali B., et al. “Intake of antioxidants and subsequentdecline in physical function in a racially/ethnically diverse population”. The Journal of Nutrition, Health and Aging5 (2015): 542-547.
  67. Yang F., et al. “Dietary antioxidants and risk of Parkinson’s disease in two population-based cohorts”. Movement Disorders11 (2017): 1631-1636.
  68. Benefits of the Mediterranean Diet: Insights from the PREDIMED Study”. Progress in Cardiovascular Diseases 1 (2015): 50-60.
  69. Asemi Z., et al. “Effects of DASH diet on lipid profiles and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized clinical trial”. Nutrition (Burbank, Los Angeles County, Calif) 30.11-12 (2014): 1287-1293.
  70. Rajaram S., et al. “Plant-Based Dietary Patterns, Plant Foods, and Age-Related Cognitive Decline”. Advances in Nutrition4 (2019): S422-S436.
  71. Dexter DT and Jenner P. “Parkinson disease: from pathology to molecular disease mechanisms”. Free Radical Biology and Medicine 62 (2013): 132-144.
  72. Ruth E Musgrove., et al. “Oxidative stress in vagal neurons promotes parkinsonian pathology and intercellular α-synuclein transfer”. Journal of Clinical Investigation 9 (2019): 3738-3753.
  73. Tiwari PC and Pal R. “The potential role of neuroinflammation and transcription factors in Parkinson disease”. Dialogues in Clinical Neuroscience1 (2017): 71-80.


Citation: Rajib Dutta and Swatilekha Roy Sarkar. "MIND Diet in Delaying Parkinsonian Signs in Elderly Population".Acta Scientific Neurology 3.1 (2020): 25-30.


Acceptance rate32%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US